Tumor Biology

, Volume 35, Issue 4, pp 2931–2939 | Cite as

Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis

Research Article

Abstract

Xeroderma pigmentosum complementation group C (XPC) gene plays a critical role in DNA damage recognition, and its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity and cancer susceptibility. Numerous epidemiological studies have investigated the associations between XPC Lys939Gln and Ala499Val polymorphisms and lung cancer susceptibility, but the conclusions are inconclusive. We searched three electronic databases (MEDLINE, EMBASE and EBSCO) for eligible publications and performed a meta-analysis assessing the associations between XPC Lys939Gln and Ala499Val polymorphisms and lung cancer risk. We also analysed the genotype-mRNA expression correlation using the data of HapMap phase II release 23 with 270 individuals from 4 ethnicities for exploring biological plausibility of our findings. We included ten published studies of 3,882 cases and 5,219 controls for Lys939Gln, and five studies with 2,605 cases and 3,329 controls for Ala499Val. When all studies were pooled, we found a significantly increased overall lung cancer risk for Lys939Gln polymorphism (recessive model: OR = 1.14, 95 % CI = 1.01–1.29, P = 0.218 for heterogeneity). Stratification analysis also showed a higher lung cancer risk in Asian populations (recessive model: OR = 1.26, 95 % CI = 1.04–1.52, P = 0.263 for heterogeneity). Interestingly, we found significant correlation between Lys939Gln genotypes and XPC mRNA expression for Asian populations as well. However, we did not observe any association between Ala499Val polymorphism and overall lung cancer risk, nor in further stratification analysis. This meta-analysis suggests that XPC Lys939Gln polymorphism may contribute to lung cancer risk, which needs further validation in single larger studies.

Keywords

XPC Single nucleotide polymorphism Lung cancer Susceptibility Meta-analysis 

References

  1. 1.
    Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000;18:2309–15.PubMedGoogle Scholar
  3. 3.
    Geacintov NE, Broyde S, Buterin T, et al. Thermodynamic and structural factors in the removal of bulky DNA adducts by the nucleotide excision repair machinery. Biopolymers. 2002;65:202–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996;56:4103–7.PubMedGoogle Scholar
  5. 5.
    Gillet LC, Scharer OD. Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem Rev. 2006;106:253–76.PubMedCrossRefGoogle Scholar
  6. 6.
    Christmann M, Tomicic MT, Roos WP, Kaina B. Mechanisms of human DNA repair: an update. Toxicology. 2003;193:3–34.PubMedCrossRefGoogle Scholar
  7. 7.
    Volker M, Mone MJ, Karmakar P, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell. 2001;8:213–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Khan SG, Muniz-Medina V, Shahlavi T, et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 2002;30:3624–31.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell. 1998;2:223–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Hollander MC, Philburn RT, Patterson AD, et al. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci U S A. 2005;102:13200–5.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Holm K, Melum E, Franke A, Karlsen TH. SNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinforma. 2010;11:600.CrossRefGoogle Scholar
  12. 12.
    Zhu ML, Shi TY, Hu HC, et al. Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations. PLoS One. 2012;7:e41500.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    International HapMap Consortium (2003) The International HapMap Project. Nature 426 (6968):789–796.Google Scholar
  14. 14.
    Stranger BE, Forrest MS, Dunning M, et al. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes. Science. 2007;315:848–53.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  16. 16.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  17. 17.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Hu ZB, Wang YG, Ma HX, et al. Association of two exonic genetic polymorphisms in the DNA repair gene XPC with risk of lung cancer in Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005;22:415–8.PubMedGoogle Scholar
  20. 20.
    Hung RJ, Baragatti M, Thomas D, et al. Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways. Cancer Epidemiol Biomarkers Prev. 2007;16:2736–44.PubMedCrossRefGoogle Scholar
  21. 21.
    Michiels S, Danoy P, Dessen P, et al. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis. 2007;28:1731–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Sakiyama T, Kohno T, Mimaki S, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005;114:730–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Hu Z, Wang Y, Wang X, et al. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer. 2005;115:478–83.PubMedCrossRefGoogle Scholar
  24. 24.
    Lee GY, Jang JS, Lee SY, et al. XPC polymorphisms and lung cancer risk. Int J Cancer. 2005;115:807–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Vogel U, Overvad K, Wallin H, et al. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett. 2005;222:67–74.PubMedCrossRefGoogle Scholar
  26. 26.
    Bai Y, Xu L, Yang X, et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case–control study. BMC Cancer. 2007;7:81.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Chang JS, Wrensch MR, Hansen HM, et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer. 2008;123:2095–104.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Raaschou-Nielsen O, Sorensen M, Overvad K, et al. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer. 2008;59:171–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Sakoda LC, Loomis MM, Doherty JA, et al. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet. 2012;3:1–17.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Shen M, Berndt SI, Rothman N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer. 2005;116:768–73.PubMedCrossRefGoogle Scholar
  31. 31.
    Landi S, Gemignani F, Canzian F, et al. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res. 2006;66:11062–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie. 1999;81:39–44.PubMedCrossRefGoogle Scholar
  33. 33.
    Thoma BS, Vasquez KM. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog. 2003;38:1–13.PubMedCrossRefGoogle Scholar
  34. 34.
    Araujo SJ, Nigg EA, Wood RD. Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome. Mol Cell Biol. 2001;21:2281–91.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Araki M, Masutani C, Takemura M, et al. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem. 2001;276:18665–72.PubMedCrossRefGoogle Scholar
  36. 36.
    Wang G, Chuang L, Zhang X, et al. The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res. 2004;32:2231–40.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000;92:1764–72.PubMedCrossRefGoogle Scholar
  38. 38.
    Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. 2004;25:729–34.PubMedCrossRefGoogle Scholar
  39. 39.
    Francisco G, Menezes PR, Eluf-Neto J, Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet. 2008;16:724–34.PubMedCrossRefGoogle Scholar
  40. 40.
    Qiu L, Wang Z, Shi X. Associations between XPC polymorphisms and risk of cancers: A meta-analysis. Eur J Cancer. 2008;44:2241–53.PubMedCrossRefGoogle Scholar
  41. 41.
    Zhang D, Chen C, Fu X, et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet. 2008;53:18–33.PubMedCrossRefGoogle Scholar
  42. 42.
    He J, Shi TY, Zhu ML, et al. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int J Cancer. 2013;133:1765–75.PubMedCrossRefGoogle Scholar
  43. 43.
    Liu C, Yin Q, Hu J, et al. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility. Tumour Biol. 2013;34:1205–13.PubMedCrossRefGoogle Scholar
  44. 44.
    Zhu ML, Yu H, Shi TY, et al. Polymorphisms in mTORC1 Genes Modulate Risk of Esophageal Squamous Cell Carcinoma in Eastern Chinese Populations. J Thorac Oncol. 2013;8:788–95.PubMedCrossRefGoogle Scholar
  45. 45.
    Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25:757–63.PubMedCrossRefGoogle Scholar
  46. 46.
    Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41:221–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39:645–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Haiman CA, Patterson N, Freedman ML, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 2007;39:638–44.PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Tomlinson I, Webb E, Carvajal-Carmona L, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007;39:984–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Zhu ML, Wang M, Shi TY, et al. No Association between TGFB1 Polymorphisms and Late Radiotherapy Toxicity: A Meta-Analysis. PLoS One. 2013;8:e76964.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of OncologyXin Hua Hospital affiliated to Shanghai Jiaotong University School of MedicineShanghaiChina
  2. 2.Department of OncologyThe First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina

Personalised recommendations